Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resonance Health Ltd (AU:RHT)
ASX:RHT
Resonance Health Ltd (RHT) Share Price & Analysis
1 Followers
RHT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.09
Previous CloseAU$0.06
Volume10.00K
Average Volume (3M)220.67K
Market Cap
AU$26.37M
Enterprise ValueAU$19.85M
Total Cash (Recent Filing)AU$6.78M
Total Debt (Recent Filing)AU$268.22K
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Aug 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding446,892,928
10 Day Avg. Volume246,092
30 Day Avg. Volume220,670
Standard Deviation0.24
R-Squared0.05
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Resonance Health Ltd News
PremiumCompany Announcements
Resonance Health Announces Performance Rights Cessation
PremiumCompany Announcements
Resonance Health Director Buys More Shares
PremiumCompany Announcements
Resonance Health Director Increases Stake
PremiumCompany Announcements
Resonance Health Receives R&D Tax Boost
PremiumCompany Announcements
Resonance Health Acquires TrialsWest to Boost GrowthPremiumCompany Announcements
Resonance Health Reports Strong Growth and ExpansionsOptions Prices
Currently, No data available
---
Ownership Overview
21.09% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
78.91% Public Companies and
Individual Investors
RHT FAQ
What was Resonance Health Ltd’s price range in the past 12 months?
Resonance Health Ltd lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
What is Resonance Health Ltd’s market cap?
Currently, no data Available
When is Resonance Health Ltd’s upcoming earnings report date?
Resonance Health Ltd’s upcoming earnings report date is Aug 27, 2024 which is in 53 days.
How were Resonance Health Ltd’s earnings last quarter?
Resonance Health Ltd released its earnings results on Feb 28, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Resonance Health Ltd overvalued?
According to Wall Street analysts Resonance Health Ltd’s price is currently Overvalued.
Does Resonance Health Ltd pay dividends?
Resonance Health Ltd does not currently pay dividends.
What is Resonance Health Ltd’s EPS estimate?
Resonance Health Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Resonance Health Ltd have?
Resonance Health Ltd has 446,892,900 shares outstanding.
What happened to Resonance Health Ltd’s price movement after its last earnings report?
Resonance Health Ltd reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Resonance Health Ltd?
Currently, no hedge funds are holding shares in AU:RHT
---
Resonance Health Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RHT Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$42.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
39.53%
12-Months-Change
Fundamentals
Return on Equity
-10.73%
Trailing 12-Months
Asset Growth
-6.50%
Trailing 12-Months
Company Description
Resonance Health Ltd
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.
---
Technical Analysis
---